BDX Becton Dickinson Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NYSE: BDX
  4. Earnings
?
Relative Growth: Rel. Growth: 50
Relative Strength: Rel. Strength: 50
Relative Valuation: Rel. Valuation: 39
Relative Profitability: Rel. Profitability: 45

EPS in 2026 (TTM): $3.32

Last Report Period Date: Jun 30, 2026

According to the most recent financial data from June 2026, the current EPS (TTM) is $3.32. Becton Dickinson's EPS for 2025 came in at $5.83, marking a decrease from $5.88 in 2024. For the quarterly period ending on Jun 30, 2026, BDX's EPS was $1.37.

BDX earnings history

Historical annual and quarterly earnings per share (EPS) data for Becton Dickinson
EPS (TTM)
$3.32
EPS Growth YoY (Quarterly)
-31.5%
EPS (Quarterly)
$1.37
EPS Growth (Quarterly)
223.4%

Becton Dickinson had an annual EPS of $5.83, marking a decrease of 0.9% from $5.88 in 2024. The quarterly EPS for the period ending Jun 30, 2026, was $1.37, marking a 31.5% decrease from the same quarter last year. BDX's TTM EPS stands at $3.32 as of June 2026. Becton Dickinson's EPS for 2024 stood at $5.88, a 18.3% increase from 2023.

BDX EPS vs price chart

BDX EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-31.5%
EPS growth YoY
-0.9%
EPS growth 3Y avg
-0.6%
EPS growth 5Y avg
16.2%

Over the last 12 months, Becton Dickinson has registered an EPS growth of -31.5% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of -0.6% per year over the past 3 years. Over the last 5 years, the company had an average EPS growth rate of 16.2%. A 10-year view shows that BDX has seen an average EPS growth of 5.4% per year.

BDX Earnings Waterfall

Breakdown of revenue, profit and net income for Becton Dickinson

BDX Earnings vs Peers

What are the earnings of BDX compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
RMD Resmed Inc 21.44 9.6% 19.6% 26.2%
LH Laboratory Corp Of America Holdings 26.14 18.6% -9.1% -8%
TMO Thermo Fisher Scientific Inc 31.59 7.2% 0% 2%
BIO Bio-Rad Laboratories Inc - Class A 44.26 142.6% N/A -26.3%
ISRG Intuitive Surgical Inc 44.68 22.3% 29.1% 21.5%
BDX Becton Dickinson & Company 55.24 -0.9% -0.6% 16.2%
XRAY DENTSPLY Sirona Inc N/A 33% N/A N/A
BAX Baxter International Inc N/A -47.2% N/A N/A
TFX Teleflex Incorporated N/A -1,462.4% N/A N/A
HBIO Harvard Bioscience Inc N/A -357.1% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.